دوره 10، شماره 2 - ( 10-1402 )                   جلد 10 شماره 2 صفحات 59-56 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheikhpour M, Sakhi H. Carbon Nanotube-Based Nanovaccines in Lung Cancer Immunotherapy. vacres 2023; 10 (2) :56-59
URL: http://vacres.pasteur.ac.ir/article-1-366-fa.html
Carbon Nanotube-Based Nanovaccines in Lung Cancer Immunotherapy. Vaccine Research. 1402; 10 (2) :56-59

URL: http://vacres.pasteur.ac.ir/article-1-366-fa.html


چکیده:   (88 مشاهده)
Conventional lung cancer therapies—including surgery, chemotherapy, and radiotherapy—are often limited by insufficient efficacy and significant adverse effects. In response, cancer immunotherapy, particularly vaccine-based approaches, has emerged as a promising strategy to improve outcomes. Carbon nanotubes (CNTs) represent a versatile nanoplatform capable of efficiently delivering antigens, adjuvants, and therapeutic agents, making them attractive candidates for nanovaccine development. This review examines the role of CNT-based nanovaccines in lung cancer immunotherapy, focusing on their mechanisms of action and therapeutic potential. Evidence indicates that CNT nanovaccines enhance antitumor immunity by promoting dendritic cell maturation, stimulating robust humoral and cellular immune responses, and reprogramming the immunosuppressive tumor microenvironment toward an immunopermissive state. Despite these promising preclinical results, clinical translation requires further optimization of CNT design and functionalization, alongside comprehensive in vivo evaluation of immunogenicity, biodistribution, and safety profiles. Overall, CNT-based nanovaccines hold considerable potential to advance lung cancer immunotherapy, though targeted research is needed to bridge the gap between experimental promise and clinical application.
متن کامل [PDF 473 kb]   (36 دریافت)    
نوع مطالعه: Review article | موضوع مقاله: Other
دریافت: 1404/11/28

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Vaccine Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2026 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.